In this study, the correlation between RIPK1 and RIPK3 with cerebral infarction volume, severity, and prognosis in AIS patients was explored, aiming to provide new targets for the treatment of AIS and bring better prognosis to patients. This evidence concerns the gene RIPK1 and androgen insensitivity syndrome.